Deruxtecan is an ADC drug-linker conjugate composed of the cleavable glycine-glycine-phenylalanine-glycine tetrapeptide-based linker, a self-immolative amino methylene spacer, and a novel topoisomerase 1 inhibitor payload that is a derivative of exatecan (DX-8951).